 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 847910
Online Users : 607
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/12750
|
| Title: | Zika virus NS3 protease pharmacophore anchor model and drug discovery |
| Authors: | Pathak, N;Kuo, YP;Chang, TY;Huang, CT;Hung, HC;Hsu, JTA;Yu, GY;Yang, JM |
| Contributors: | National Institute of Infectious Diseases and Vaccinology;Institute of Biotechnology and Pharmaceutical Research |
| Abstract: | Zika virus (ZIKV) of the flaviviridae family, is the cause of emerging infections characterized by fever, Guillain-Barré syndrome (GBS) in adults and microcephaly in newborns. There exists an urgent unmet clinical need for anti-ZIKV drugs for the treatment of infected individuals. In the current work, we aimed at the promising virus drug target, ZIKV NS3 protease and constructed a Pharmacophore Anchor (PA) model for the active site. The PA model reveals a total of 12 anchors (E, H, V) mapped across the active site subpockets. We further identified five of these anchors to be critical core anchors (CEH1, CH3, CH7, CV1, CV3) conserved across flaviviral proteases. The ZIKV protease PA model was then applied in anchor-enhanced virtual screening yielding 14 potential antiviral candidates, which were tested by in vitro assays. We discovered FDA drugs Asunaprevir and Simeprevir to have potent anti-ZIKV activities with EC50 values 4.7 µM and 0.4 µM, inhibiting the viral protease with IC50 values 6.0 µM and 2.6 µM respectively. Additionally, the PA model anchors aided in the exploration of inhibitor binding mechanisms. In conclusion, our PA model serves as a promising guide map for ZIKV protease targeted drug discovery and the identified ‘previr’ FDA drugs are promising for anti-ZIKV treatments. |
| Date: | 2020-06-02 |
| Relation: | Scientific Reports. 2020 Jun 2;10:Article number 8929. |
| Link to: | http://dx.doi.org/10.1038/s41598-020-65489-w |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2045-2322&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000560796300019 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85085689914 |
| Appears in Collections: | [余冠儀] 期刊論文
[徐祖安] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SCP85085689914.pdf | | 4513Kb | Adobe PDF | 271 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
